tiprankstipranks
Arcutis Biotherapeutics (ARQT)
NASDAQ:ARQT
US Market

Compare Arcutis Biotherapeutics (ARQT) vs. Competitors

962 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Arcutis Biotherapeutics
$24.61
$3.05B
-228.91
85.18%
8 Buy
1 Hold
0 Sell
Strong Buy
Travere Therapeutics
$31.68
$2.92B
-67.82
123.89%
12 Buy
2 Hold
0 Sell
Strong Buy
Disc Medicine
$66.85
$2.53B
-13.21
93.32%
11 Buy
0 Hold
0 Sell
Strong Buy
Harmony Biosciences Holdings
$27.62
$1.65B
13.56
1.21%
4 Buy
3 Hold
1 Sell
Moderate Buy
Tarsus Pharmaceuticals
$68.76
$3.06B
-51.51
61.08%
8 Buy
1 Hold
0 Sell
Strong Buy
Recursion Pharmaceuticals
$3.19
$1.79B
-2.84
-14.61%
1 Buy
2 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ARQT
Arcutis Biotherapeutics
24.61
11.17
83.11%
TVTX
Travere Therapeutics
31.68
18.19
134.84%
IRON
Disc Medicine
66.27
31.04
88.11%
HRMY
Harmony Biosciences Holdings
28.47
-0.52
-1.79%
TARS
Tarsus Pharmaceuticals
71.89
27.77
62.94%
RXRX
Recursion Pharmaceuticals
3.39
-1.12
-24.83%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts